Professor Jonathan Cavanagh
David Heal
Dr Jordi Lopez-Tremoleda
Dr Emma Robinson
Professor Amin Rostami-Hodjegan
Professor S Clare Stanford
Jonathan Cavanagh is Professor of Psychiatry at the University of Glasgow and an honorary consultant neuropsychiatrist at the Queen Elizabeth University Hospital.
He leads a group that is focused on exploring mechanisms underlying immune-mediated behaviours relevant to major psychiatric disorders using the techniques of molecular neuroimmunology.
David is an Executive Director and co-founder of DevelRx Ltd. DevelRx provides consultancy support to pharmaceutical companies developing novel CNS drugs. His initial training was as a neuroscientist and behavioural pharmacologist at the University of Oxford.
After a career in academic research, he joined the pharmaceutical industry with responsibility for CNS and metabolic drug research at Boots Pharmaceuticals and BASF Pharma. He co-founded and for 20 years was an Executive Director at the non-clinical CRO, RenaSci, before leaving to set up DevelRx. His experience in R&D encompasses the approval of 15 novel drugs for indications including ADHD, binge-eating disorder, schizophrenia, Parkinson’s disease, epilepsy, opiate withdrawal, opiate-induced adverse events, anaesthesia, haemodialysis-induced pruritis, and obesity.
He was awarded a DSc by Kings College, London University for his contribution to pharmacology research. He is a Visiting Professor at the University of Bath, a Fellow of the Royal Society of Chemistry and a member of the American College of Neuropsychopharmacology. He has authored more than 200 scientific articles and reviews, co-edited books and journal special issues on a range of clinical topics and serves on the editorial boards of several international scientific journals.
As the University Veterinarian I provide advice on animal health and care for the animals used in research procedures at Queen Mary, supporting veterinary care and advising on experimental methodologies to promote the implantation of the 3Rs principles and safeguarding the welfare of the animals. I also support the training and education of Queen Mary staff undertaking animal experimentation procedures, advising on the implementation of the animal license projects in accordance with the UK/EU regulatory requirements.
As a Senior Lecturer at the Centre for Trauma Sciences, I oversee the development and validation of experimental models for effective trauma translation. My research brings together complex models of trauma, haemorrhage, shock, coagulopathy and central nervous injury to facilitate the full translation of experimental work into clinical practice. Having worked extensively in preclinical imaging, I am also very interested in the implementation of forefront imaging modalities in our models, to maximise their translational efficacy and to support the development of new biomarkers.
I also hold an MSc in Bioethics and I am currently a member of the Animal Welfare and Ethical Review Body at Queen Mary. I am also Editor in Chief of Laboratory Animals and sit on the Council of the Laboratory Animals Veterinary Association (LAVA) and Laboratory Animas Science Association (LASA).
As a FHEA I also teach on various BSc, iBSc, MSc and PBL programmes within Barts and The London School of Medicine and Dentistry, associated to preclinical modelling, imaging technologies and animal welfare and regulations.
Emma completed her BSc in Pharmacology in Bristol in 1995 and PhD in Psychopharmacology in 1999 supervised by Prof David Nutt, Dr Alan Hudson and Dr Helen Jackson.
She was awarded an RCUK Academic Fellowship, co-funded by the BPS Integrative Pharmacology Fund, which provided an opportunity to work at the University of Cambridge, Experimental Psychology Department with Profs Trevor Robbins and Jeffery Dalley.
Now based in Bristol’s School of Physiology, Pharmacology and Neuroscience, Emma’s research investigates the neural and neurochemical mediators of normal cognitive and emotional behaviour and their disruption in psychiatric disorders, particularly depression. Her work on novel rodent models for depression research has also provided an opportunity to undertake objective assessments of laboratory animal welfare.
Alongside research, Emma is involved in teaching across the science and professional programmes; development of online learning resources; and is actively involved in public engagement in science, including organising the Bristol Neuroscience Festival.
